Brown Advisory Inc. Sells 153,096 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Brown Advisory Inc. trimmed its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 7.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,932,930 shares of the company's stock after selling 153,096 shares during the period. Brown Advisory Inc. owned about 2.23% of HealthEquity worth $170,813,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of the stock. Wealthfront Advisers LLC bought a new stake in HealthEquity during the 4th quarter worth approximately $10,304,089,000. Vanguard Group Inc. boosted its stake in HealthEquity by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 8,976,091 shares of the company's stock worth $861,256,000 after purchasing an additional 99,624 shares in the last quarter. FMR LLC grew its holdings in shares of HealthEquity by 2.4% during the fourth quarter. FMR LLC now owns 5,415,800 shares of the company's stock worth $519,646,000 after purchasing an additional 125,684 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of HealthEquity by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 2,089,398 shares of the company's stock valued at $200,522,000 after buying an additional 10,421 shares in the last quarter. Finally, Invesco Ltd. raised its holdings in shares of HealthEquity by 0.8% in the fourth quarter. Invesco Ltd. now owns 1,624,773 shares of the company's stock valued at $155,897,000 after buying an additional 12,425 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, EVP Michael Henry Fiore sold 1,794 shares of HealthEquity stock in a transaction dated Monday, July 7th. The shares were sold at an average price of $101.73, for a total value of $182,503.62. Following the completion of the transaction, the executive vice president owned 53,225 shares of the company's stock, valued at $5,414,579.25. This trade represents a 3.26% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Elimelech Rosner sold 58,000 shares of the business's stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $112.56, for a total transaction of $6,528,480.00. Following the transaction, the executive vice president owned 75,689 shares in the company, valued at $8,519,553.84. This represents a 43.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 291,744 shares of company stock valued at $32,705,007. 1.50% of the stock is owned by insiders.

HealthEquity Stock Down 2.7%

HQY stock traded down $2.67 during midday trading on Friday, hitting $94.52. The company's stock had a trading volume of 1,106,970 shares, compared to its average volume of 868,231. The company's fifty day moving average price is $100.98 and its 200 day moving average price is $98.41. The company has a debt-to-equity ratio of 0.50, a current ratio of 4.06 and a quick ratio of 4.06. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $116.65. The stock has a market capitalization of $8.17 billion, a P/E ratio of 68.99, a PEG ratio of 1.50 and a beta of 0.49.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.81 by $0.16. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%. The business had revenue of $330.80 million for the quarter, compared to the consensus estimate of $322.25 million. During the same quarter in the previous year, the business earned $0.80 earnings per share. As a group, equities research analysts predict that HealthEquity, Inc. will post 2.32 EPS for the current year.

Analysts Set New Price Targets

Several research firms have weighed in on HQY. Barrington Research raised their price objective on shares of HealthEquity from $112.00 to $125.00 and gave the company an "outperform" rating in a research report on Thursday, June 5th. Royal Bank Of Canada raised their price target on shares of HealthEquity from $112.00 to $117.00 and gave the company an "outperform" rating in a report on Wednesday, June 4th. Raymond James Financial reaffirmed a "strong-buy" rating and set a $120.00 price objective (up previously from $115.00) on shares of HealthEquity in a report on Tuesday. Deutsche Bank Aktiengesellschaft increased their price objective on HealthEquity from $98.00 to $115.00 and gave the company a "buy" rating in a research report on Thursday, June 5th. Finally, Wall Street Zen upgraded HealthEquity from a "hold" rating to a "buy" rating in a research report on Friday, June 6th. One research analyst has rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Buy" and a consensus price target of $118.55.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.